Molecular Partners and Orano Med Team Up for Alpha Radiotherapies for Cancer (MOLN: NASDAQ)


cancer patient and modern treatment

Xesai

  • Biotechnology company in clinical phase Molecular Partners (NASDAQ:CLOUD) and Orano Med, a radiopharmaceutical company in the clinical phase expand their strategic collaboration.
  • The terms of the new agreement include the development of six additional targeted alpha therapeutic candidates, now representing a total of ten potential candidates.



Source link

  • Related Posts

    North Korea’s suicidal soldiers pose new challenge for Ukraine in war against Russia By Reuters

    By Ju-min Park and John Geddie SEOUL (Reuters) – After a battle with Russia in the western Kursk region this week, Ukrainian special forces have recovered the bodies of more…

    ‘We wouldn’t do this’: ITC chief Sanjiv Puri as debate over 90-hour work week continues

    Sanjiv Puri, chairman of cigarette-to-consumer goods conglomerate ITC, has also weighed in on the ongoing 90-hour work week debate. Puri said in a recent interview that rather than the number…

    Leave a Reply

    Your email address will not be published. Required fields are marked *